Prism Medico & Pharmacy (BOM:512217) Other Stockholders Equity: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512217 Prism Medico & Pharmacy Ltd BOM:512217
43 GF Score
Price ₹29.12
GF Value ₹9.31
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Prism Medico & Pharmacy Other Stockholders Equity?

Prism Medico & Pharmacy BOM:512217 -0.61% 43 Other Stockholders Equity is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:512217 with a GF Score™ of 43/100 and a GF Value™ of ₹9.31 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Prism Medico & Pharmacy's Other Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Prism Medico & Pharmacy's annual Other Stockholders Equity increased from Mar. 2024 (₹-0.00 Mil) to Mar. 2025 (₹0.00 Mil) but then stayed the same from Mar. 2025 (₹0.00 Mil) to Mar. 2026 (₹0.00 Mil).

Prism Medico & Pharmacy Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Prism Medico & Pharmacy's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prism Medico & Pharmacy Other Stockholders Equity Chart

Prism Medico & Pharmacy Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 90.98 -0.00 0.00 0.00

Prism Medico & Pharmacy Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:512217
43GF Score
Prism Medico & Pharmacy Ltd BOM:512217
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prism Medico & Pharmacy Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹0.00 Mil mean?
Prism Medico & Pharmacy (BOM:512217) has a Other Stockholders Equity of ₹0.00 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Prism Medico & Pharmacy and its competitors.
Is Prism Medico & Pharmacy's Other Stockholders Equity too high?
Prism Medico & Pharmacy's current Other Stockholders Equity is ₹0.00 Mil. Overall, Prism Medico & Pharmacy has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's Other Stockholders Equity compare to ADM and BG?
Prism Medico & Pharmacy's Other Stockholders Equity of ₹0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Consumer Packaged Goods company?
A good Other Stockholders Equity depends on the Consumer Packaged Goods industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Prism Medico & Pharmacy and its competitors. Prism Medico & Pharmacy's current Other Stockholders Equity is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹9.31, compared to a current price of ₹29.12 — trading 212.8% above its estimated fair value. The current Other Stockholders Equity is ₹0.00 Mil. Prism Medico & Pharmacy's overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current Other Stockholders Equity is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?

Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued. The current stock price of ₹29.12 is trading 212.8% above its estimated GF Value™ of ₹9.31. GuruFocus considers Prism Medico & Pharmacy to be Significantly Overvalued.

Key valuation signals for BOM:512217:

  • Other Stockholders Equity: ₹0.00 Mil
  • GF Value™: ₹9.31 vs. price of ₹29.12 (212.8% above fair value)
  • GF Score™: 43/100 with 3 warning signs

No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prism Medico & Pharmacy Business Description

Address C/o. Sunrise Enterprises, Suketi Road, Sirmaur District, Kala Amb, HP, IND, 173030
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
43GF Score

Get the complete analysis for BOM:512217

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹29.12
Price
₹9.31
GF Value